Showing results (251-260 of 474) with videos related to

Sort By:
Pageof 48
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2025
Harnessing Egocentric Networks to Inform an Enhanced Social Network Strategy in a Southern US "Ending the HIV Epidemic" RegionGuozheng Yang, Ian Dale, Meagan Zarwell, et al.
Molecular Biology of the Cell|February 27, 2009
Rab11b regulates the apical recycling of the cystic fibrosis transmembrane conductance regulator in polarized intestinal epithelial cellsMark R Silvis, Carol A Bertrand, Nadia Ameen, et al.
AIDS and Behavior|January 8, 2009
Identifying people with acute HIV infection: demographic features, risk factors, and use of health care among individuals with AHI in North CarolinaLisa B Hightow-Weidman, Carol E Golin, Kelly Green, et al.
Biochemistry|October 25, 2007
Complete inhibition of the Pdr5p multidrug efflux pump ATPase activity by its transport substrate clotrimazole suggests that GTP as well as ATP may be used as an energy sourceJohn Golin, Zachary N Kon, Chung-Pu Wu, et al.
HIV Clinical Trials|October 31, 2002
Impact of antiretroviral regimen switches on adherenceLoren G Miller, Carol E Golin, Ron D Hays, et al.
AIDS and Behavior|October 25, 2013
HIV and stigma in Liuzhou, ChinaJuxiang Hua, Catherine Boland Emrick, Carol E Golin, et al.
Digestive Diseases and Sciences|February 2, 2021
"If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis CDonna M Evon, Hannah P Kim, Angela Edwards, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|February 15, 2017
Implementing a Prison Medicaid Enrollment Program for Inmates with a Community Inpatient HospitalizationDavid L Rosen, Catherine A Grodensky, Anna R Miller, et al.
Journal of Medical Internet Research|July 7, 2005
How new subscribers use cancer-related online mailing listsBarbara K Rimer, Elizabeth J Lyons, Kurt M Ribisl, et al.
Plos One|November 23, 2020
Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitorsDwight E Yin, Christina Ludema, Stephen R Cole, et al.
Pageof 48